#CellCollaboration
Leadgene Biomedical, Inc. has partnered with BICO Group's CYTENA and CYTENA BPS (CYTENA Bioprocess Solutions) to create a competitive Cell Line Development (CLD) platform. This collaboration aims to enhance cell cultivation precision and technological advancement with real-time monitoring and automation.
Chasel Yung-Chun Chuang, Chairman of Leadgene Biomedical, celebrates the breakthrough in cell line platform and facility development, which has expanded the sector's technological prowess.
The patented suspension culture technique ensures stable cell growth, maximizing yield and efficiency while reducing costs. This collaboration elevates technical excellence in #biopharmaceuticals and lays a robust foundation for extensive clinical applications.
Read more at https://lnkd.in/gTYt_DBk
Follow #Globalbio for more updates on #biotech innovations!
Leadgene Biomedical, Inc. has partnered with BICO Group's CYTENA and CYTENA BPS
撰文GlobalBio & Investment
日期2024-03-31
![](/upload/article/_images/1711610400661.jpg)
Leadgene Biomedical, Inc. has partnered with BICO Group's CYTENA and CYTENA BPS